Bank of Nova Scotia’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-445,625
Closed -$44.3M 1012
2019
Q3
$44.3M Sell
445,625
-268,529
-38% -$25.5M 0.13% 150
2019
Q2
$65.5M Buy
714,154
+17,398
+2% +$1.65M 0.27% 80
2019
Q1
$65.7M Buy
696,756
+376,236
+117% +$32.9M 0.26% 88
2018
Q4
$20.5M Buy
320,520
+85,330
+36% +$6.3M 0.1% 180
2018
Q3
$21M Buy
235,190
+144,429
+159% +$12.8M 0.09% 197
2018
Q2
$7.21M Sell
90,761
-157,159
-63% -$13M 0.04% 299
2018
Q1
$22.1M Sell
247,920
-27,618
-10% -$2.65M 0.11% 172
2017
Q4
$28.8M Buy
275,538
+133,205
+94% +$15M 0.13% 161
2017
Q3
$20.8M Sell
142,333
-49,018
-26% -$6.68M 0.12% 164
2017
Q2
$24.9M Sell
191,351
-669
-0.3% -$82K 0.13% 148
2017
Q1
$23.9M Buy
192,020
+148,375
+340% +$17.8M 0.1% 172
2016
Q4
$5.05M Buy
43,645
+27,907
+177% +$3.11M 0.03% 254
2016
Q3
$1.65M Buy
15,738
+130
+0.8% +$14.1K 0.01% 336
2016
Q2
$1.54M Buy
15,608
+860
+6% +$89K 0.01% 318
2016
Q1
$1.48M Sell
14,748
-175,920
-92% -$18.1M 0.01% 322
2015
Q4
$22.8M Buy
190,668
+175,940
+1,195% +$20.4M 0.12% 108
2015
Q3
$1.59M Buy
14,728
+400
+3% +$49.6K 0.01% 284
2015
Q2
$1.66M Buy
14,328
+615
+4% +$70.3K 0.01% 241
2015
Q1
$1.58M Buy
13,713
+131
+1% +$15.7K 0.01% 243
2014
Q4
$1.52M Buy
13,582
+428
+3% +$45.1K 0.01% 245
2014
Q3
$1.25M Buy
13,154
+596
+5% +$53.8K 0.01% 265
2014
Q2
$1.08M Sell
12,558
-94,432
-88% -$7.18M ﹤0.01% 278
2014
Q1
$7.47M Sell
106,990
-50,430
-32% -$3.99M 0.03% 173
2013
Q4
$13.3M Buy
157,420
+146,686
+1,367% +$11.6M 0.06% 147
2013
Q3
$826K Sell
10,734
-202,314
-95% -$14.2M ﹤0.01% 285
2013
Q2
$12.5M Buy
+213,048
New +$12.8M 0.06% 125

Other funds holding CELG

Bank of Nova Scotia's CELG Position: Q4 2019 in Review

Bank of Nova Scotia sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 445,625 shares — an estimated $44.3M sold.

Bank of Nova Scotia first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $65.7M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bank of Nova Scotia reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bank of Nova Scotia sold 445,625 Celgene Corp shares in Q4 2019, an estimated $44.3M.
  • Bank of Nova Scotia first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bank of Nova Scotia's Celgene Corp position peaked at $65.7M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bank of Nova Scotia's 13F filing for Q4 2019, filed 13 Feb 2020.